Is your employer cutting off your access to GLP-1 drugs? Tell us.
GLP-1 drugs have transformed the lives of many Massachusetts residents who have long struggled to lose weight. But…
QuickCheck: Does camphor cause cancer?
CAMPHOR has been used for centuries in a range of medical, industrial and cultural practices, particularly in traditional…
Atorvastatin Recall May Affect Hundreds of Thousands of Patients – and Reflects FDA's Troubles Inspecting Medicines Made Overseas – UConn Today
Atorvastatin Recall May Affect Hundreds of Thousands of Patients – and Reflects FDA’s Troubles Inspecting Medicines Made Overseas UConn…
Ozempic and Wegovy May Slow Alcohol Absorption and Intoxication
November 6, 2025 4 min read Why Drugs Like Ozempic Can Make People Drink Less Alcohol A small…
Paxton makes “extraordinary request” to block Tylenol maker from paying shareholders
by Eleanor Klibanoff, The Texas Tribune November 6, 2025 Texas Attorney General Ken Paxton is asking a judge…
DVLA warning as drivers could lose licence over three common medications
The DVLA has issued a warning to drivers, road users and motorists that they could have their driving…
Pharmacy settles lawsuit over counterfeit Ozempic sales
IOWA’S NEWS LEADER. KAYLA. THANKS. NEW AT SIX, A PHARMACY IN EASTERN IOWA ACCUSED OF SELLING COUNTERFEIT OZEMPIC…
Drug company representative collapses during Oval Office event
A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President…
Over Half a Million Blood Pressure Pills Recalled: Is Yours on the List?
If you or someone in your household takes blood pressure medication, now is the time to check your…
U.S. deal could cut costs for popular weight-loss drugs. What’s that mean for Canada?
Listen to this article Estimated 4 minutes The audio version of this article is generated by text-to-speech, a…
Drug company representative collapses during Oval Office event
A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President…
FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s lumateprone (Caplyta) as an adjunctive therapy for…